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Uniformly 32P-labeled bacteriophage T5 leucine tRNA has been isolated by two-dimensional gel electro- 
phoresis from phage-infected E. coli cells. Its nucleotide sequence has been determined by conventional tech- 
niques using TLC on cellulose for oligonucleotide fractionation: 
pGGGGCUAUGCUGGAACDGmGDAGACAAUACGGCCUUAGm6AUYCCGUAGCUUAAA 
UGCGUGGGAGTYCGAGUCUCCCUAGCCCCACCAoh. 
This tRNA has anticodon sequence UAG, which can presumably recognize all the four leucine-specific 
codons (CUN). The main feature of T5 tRNAku is the absence of the A,,-& and Cjl-Y,, pairing in the 
D and anticodon stems, respectively. 
Bacteriophage T5 tRNA- Nucleotide sequence 
1. INTRODUCTION 
It has been shown that at least 30 stable RNAs, 
consisting mainly of tRNA species, are coded for 
by bacteriophage TS [ 1,2]. During the phage infec- 
tion their synthesis does not interfere with rapidly 
diminished E. coli tRNA synthesis. Thus, it is 
possible to label phage-specific tRNAs in vivo 
without visible labelling of those of E. coli [2,3]. 
Subsequent isolation of individual tRNA species 
can be performed by 2-dimensional poly- 
acrylamide gel electrophoresis. The fractionation 
pattern is shown in fig.1. 
Here, we present the nucleotide sequence of 
bacteriophage T5 tRNALe” which corresponds to 
one of the most intensive spots (spot 3 [2]). It has 
leucine-specific anticodon UAG, and does accept 
this amino acid. 
2. MATERIALS AND METHODS 
Procedures for purifying tRNALeU and 
establishing its nucleotide sequence were as 
described [3]. Some details of RNA and 
oligonucleotide fractionation are presented in the 
figure legends. 
3. RESULTS 
Uniformly 32P-labeled phag - p e s ecific tRNALeU 
was isolated from bacteriophage TS infected E. 
coli cells [3]. A practically homogeneous prepara- 
tion of this tRNA was obtained using 
2-dimensional gel electrophoresis (fig. 1). Its 
nucleotide sequence was determined essentially by 
conventional techniques [4]. The only difference 
was that TLC on cellulose was applied for the frac- 
tionation of different oligonucleotide mixtures [3]. 
Fig.2 shows the resolution and nucleotide sequence 
of the products obtained by complete digestion of 
tRNALeU with pancreatic and Tr RNases. The ap- 
proaches for the oligonucleotide structure deter- 
mination were as in [3]. The sequence of 
oligonucleotides t13’ and t14 was established by 
analysis of the products obtained from RNase UZ 
digestion of their mixture. Individual oli- 
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Fig.1. Two-dimensional polyacrylamide gel 
trophoresis of bacteriophage T5 32P-labeled 4-5 S 
RNAs. Electrophoresis was in 10% polyacrylamide/7 M 
urea/Tris-borate (10 V/cm, 1S’C) in the first dimension 
and in 2O@i’o polyacrylamideN M urea/Tris-borate 
(15 V/cm) in the second. The position of tRNALCU is 
indicated. 
gonucleotides p17 and p18 were isolated from 5 ’ - 
and 3 ‘-terminal fragments of the tRNA molecule 
split at the anticodon with RNase Tr. 
Modified nucleotides were characterized by their 
mobilities on 2-dimensional TLC [5] (fig.3). The 
extent of Gm and m6A modification did not exceed 
70%, and was no more than 20% in the case of 
D17. The incomplete modification resulted in the 
appearance of the oligonucleotides t11, t 13 ’ , p9’ 
and ~13’. 
The final sequence of T5 tRNALeU was deduced 
from the data on the analysis of large fragments 
generated by partial hydrolysis of the tRNA with 
RNase Tr or endonuclease Sr. Its cloverleaf struc- 
ture is shown in fig.4. The leucine acceptor activity 
of this tRNA was proved in the experiments on 
aminoacylation of unlabeled tRNA as described 
for T5 tRNAG1” [3]. 
4. DISCUSSION 
Bacteriophage T5 transfer RNAs have been 
shown to have a number of differences from the 
generalized cloverleaf structure [6]. One of the 
peculiarities of T5 tRNAL’” is the absence of the 
pairing between residues COO-A25, and as a result, 
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Fig.2. Two-dimensional TLC on cellulose plates (16 x 
16 cm) of the complete digestion products of 32P-labeled 
tRNALe” with RNase Tr (a) and pancreatic RNase (b). 
Chromatography was in isobutyric acid/O.5 M NH40H 
(5:3, v/v, pH 3.7) in the first dimension and in t- 
butanoW0.075 M ammonium formate (pH 3.8) (1: 1, 
v/v, pH 4.8) at 15°C in the second. Each system was 
developed twice in turns. The sequence of the 
corresponding fragments is to the right of the 
fingerprints. 
the D stem has only 2 base pairs. A similar 
peculiarity was observed in the case of T5 serine 
tRNAs and some mitochondrial tRNAs [6]. The 
next unusual feature of tRNALe” is the absence of 
Csr-*sG pairing which extends the anticodon loop 
up to 9 nucleotide residues. It should be mentioned 
that such deviations, nevertheless, do not affect its 
acceptor activity. 
The extent of the sequence homology between 
T5 tRNALe” and other leucine tRNAs, including 
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Fig.3. Two-dimensional separation of RNase T2 digest 
of tRNALeU by chromatography on a thin-layer cellulose 
plate according to [S]. 
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Fig.4. Cloverleaf structure of bacteriophage TS 
tRNALeU. The numbering system of nucleotides is 
according to the numbering of tRNAPhe from yeast [6]. 
those from E. coli and phage T4, varies within the 
range 50-65Vo (variable loops are not considered 
in this comparison). A surprisingly high degree of 
homology of T.5 tRNALeU is shown with bean 
(78%) and maize (77%) chloroplast leucine 
tRNAs, especially in the acceptor and anticodon 
stems. Whether this similarity reflects any evolu- 
tionary regularities or such high sequence 
homology is quite accidental remains as yet 
unclear. 
Like T5 and mitochondrial tRNAs, corre- 
sponding to amino acids with Ccodon families, T5 
tRNALCU has unmodified uridine in the first posi- 
tion of the anticodon (U34). This is distinct from 
the situation in tRNAs from prokaryotes and from 
eukaryotic cytoplasm in which a U residue at the 
first position is always modified [6], the exceptions 
being 2 chloroplast leucine tRNAs and yeast 
tRNAL”” [6]. It is generally accepted that any 
modification in the wobble position affects tRNA 
decoding properties. In the case of tRNAs belong- 
ing to 4-codon families, the absence of U modifica- 
tion in the first anticodon position leads to the ap- 
pearance of the ability of these tRNAs to recognize 
all 4 possible codons [7-91. Although we did not 
study the decoding properties of T5 tRNALeU, it is 
reasonable to suppose that it is also able to read all 
the 4 leucine codons (CUN), but apparently with 
different efficiency [lo]. T5 tRNA& should 
preferentially recognize the CUA codon, which is 
rarely used in the E. cob genetic code, and the cor- 
responding isoacceptor E. coli tRNA is represented 
by the minor fraction [lo]. It has been previously 
shown that most phage T4 tRNAs have anticodons 
specific for rarely occurring E. coli codons which 
at the same time are frequently used in the T4 
genome. On the strength of this fact, phage- 
specific tRNAs were supposed to optimize the 
translation of phage mRNAs [ 111. Unfortunately, 
lack of information on the codon usage does not 
permit us to clarify this question in the case of 
bacteriophage T5. 
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